 |
|
|
|
|
Iowa Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2022 replacing IowaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
AstraZeneca
| | | | | Phone: | (816) 836-5152 | | Year Established: | 1999 | | Ticker: | AZN | | Exchange: | NYSE | | Main Contact: | Pascal Soriot, CEO | | | | Other Contacts: | Pam Cheng, Executive VP, Operations
Jeff Pott, General Counsel
Katarina Ageborg, Chief Compliance Officer
Sean Bohen, Executive VP & CMO
Marc Dunoyer, CFO
| | | | Company Description | | AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of diseases in three main therapy areas - respiratory, inflammation, autoimmune disease (RIA), cardiovascular and metabolic disease (CVMD) and oncology – as well as in infection and neuroscience. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. | |
|
|
|
|
|
|
|
